Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Fresenius Kabi
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
50.0%
+2.8% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:DominantThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Baxter International
Competitor Displacement Rate
18.0%
Competitors are displacing Fresenius Kabi in 18.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Fresenius Kabi holds a strong position in generic intravenous drugs and medical devices. Baxter is a key competitor, potentially gaining by offering a wider portfolio of infusion therapies and drug delivery systems.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[baxter.com][جروم.com]⚠️ Identified Vulnerability:Portfolio Breadth
Primary Threat Identified:Baxter International
Target Persona:Pharmacy Directors
🚨 Threat Velocity:4/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)